Patent 8652497 was granted and assigned to Purdue Pharma on February, 2014 by the United States Patent and Trademark Office.
Disclosed in certain embodiments is an oral dosage form comprising a therapeutically effective amount of a drug susceptible to abuse; and an effective amount of an irritant to impart an irritating sensation to an abuser upon administration of said dosage form after tampering.